IKK Signals in Lymphocyte Physiology and Pathology
淋巴细胞生理学和病理学中的 IKK 信号
基本信息
- 批准号:7154078
- 负责人:
- 金额:$ 44.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-12-01 至 2008-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntigen ReceptorsAntigensApoptoticAutoimmune ProcessB lymphoid malignancyB-Cell DevelopmentB-Cell LymphomasB-LymphocytesCandidate Disease GeneCatalytic DomainCell MaintenanceCellsClassCollaborationsComplementComplexDevelopmentGene TargetingInflammatoryLaboratoriesLymphocyteLymphomagenesisMaintenanceMalignant - descriptorMediatingModelingMutationNF-kappa BPathologyPathway interactionsPatternPhasePhosphotransferasesPhysiologyProcessPublicationsPurposeReactionReceptor SignalingReceptors, Antigen, B-CellRoleSignal PathwaySignal TransductionStagingStimulusSurfaceSystemT-LymphocyteTechniquesTestingUp-RegulationWorkWritingautoreactive B cellautoreactivitycell typeconserved helix-loop-helix ubiquitous kinasecytokinein vivoreceptorresearch studytherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Signaling through the NF-kB pathway is of critical importance for T and B lymphocyte maturation, maintenance and function. It is also involved in autoimmune reactions performed by these cells and contributes to the survival of certain classes of B cell lymphomas. Critical components in this pathway are the IkB-kinases (IKKs) which activate NF-kB signaling upon their own activation by pro-inflammatory and antigen receptor mediated signals delivered to the cells. IKK signaling can either involve the IKK signal some consisting of IKK1, IKK2 and the NEMO protein, or proceed through IKK1 activation alone. The underlying hypothesis of the present proposal is that the activation of these two pathways, either in combination or separately, is essential for T and B cells to mature, survive and perform their various functions, and also for the promotion of certain B cell malignancies. We will therefore explore in which way the inactivation of either pathway, or its enforced activation, affect the maturation, functional activities and malignant transformation of T and/or B cells at various stages of development. Rescue experiments will identify the downstream targets of IKK signaling which are responsible for cellular maintenance, and also establish whether IKK signaling is sufficient for cellular survival in the absence of receptors such as the antigen and BAFF receptor, known to be required for B cell maintenance in normal physiology. We will also define the role of cell-autonomous IKK signals in T and B cell mediated autoreactivity. Cell type-specific activation and inactivation of IKKs will be used for this purpose, exploiting techniques of conditional gene targeting which we have established in the past.
描述(由申请方提供):通过NF-κ B通路的信号传导对于T和B淋巴细胞的成熟、维持和功能至关重要。它还参与这些细胞进行的自身免疫反应,并有助于某些类型的B细胞淋巴瘤的生存。该途径中的关键组分是IkB-激酶(IKK),其在自身被递送至细胞的促炎和抗原受体介导的信号激活后激活NF-kB信号传导。IKK信号传导可以涉及IKK信号,其中一些由IKK 1、IKK 2和NEMO蛋白组成,或者通过IKK 1单独活化进行。本发明的基本假设是,这两种途径的激活,无论是组合的还是单独的,对于T和B细胞成熟、存活和执行它们的各种功能是必需的,并且对于某些B细胞恶性肿瘤的促进也是必需的。因此,我们将探讨在何种方式的失活途径,或其强制激活,影响成熟,功能活动和恶性转化的T和/或B细胞在不同的发展阶段。拯救实验将鉴定负责细胞维持的IKK信号传导的下游靶标,并且还确定IKK信号传导是否足以在不存在受体如抗原和BAFF受体的情况下维持细胞存活,已知受体是正常生理学中B细胞维持所需的。我们还将确定细胞自主IKK信号在T和B细胞介导的自身反应性中的作用。IKK的细胞类型特异性激活和失活将用于此目的,利用我们过去建立的条件基因靶向技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KLAUS RAJEWSKY其他文献
KLAUS RAJEWSKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KLAUS RAJEWSKY', 18)}}的其他基金
The Role of B-Cell Receptor and NF<B in Germinal Center B-Cell Lymphomas
B 细胞受体和 NF<B 在生发中心 B 细胞淋巴瘤中的作用
- 批准号:
7156134 - 财政年份:2006
- 资助金额:
$ 44.8万 - 项目类别:
Role of RNA silencing in B cell development and function
RNA 沉默在 B 细胞发育和功能中的作用
- 批准号:
6902989 - 财政年份:2005
- 资助金额:
$ 44.8万 - 项目类别:
Role of RNA silencing in B cell development and function
RNA 沉默在 B 细胞发育和功能中的作用
- 批准号:
7367061 - 财政年份:2005
- 资助金额:
$ 44.8万 - 项目类别:
Role of RNA silencing in B cell development and function
RNA 沉默在 B 细胞发育和功能中的作用
- 批准号:
7017769 - 财政年份:2005
- 资助金额:
$ 44.8万 - 项目类别:
Role of RNA silencing in B cell development and function
RNA 沉默在 B 细胞发育和功能中的作用
- 批准号:
7196405 - 财政年份:2005
- 资助金额:
$ 44.8万 - 项目类别:
Role of RNA silencing in B cell development and function
RNA 沉默在 B 细胞发育和功能中的作用
- 批准号:
7572950 - 财政年份:2005
- 资助金额:
$ 44.8万 - 项目类别:
IKK Signals in Lymphocyte Physiology and Pathology
淋巴细胞生理学和病理学中的 IKK 信号
- 批准号:
6830767 - 财政年份:2003
- 资助金额:
$ 44.8万 - 项目类别:
BCR signaling during B cell development and maintenance
B 细胞发育和维持期间的 BCR 信号传导
- 批准号:
6702282 - 财政年份:2003
- 资助金额:
$ 44.8万 - 项目类别:
TOWARDS A MOUSE MODEL OF CLASSICAL HODGKIN'S DISEASE
经典霍奇金病的小鼠模型
- 批准号:
6904702 - 财政年份:2003
- 资助金额:
$ 44.8万 - 项目类别:
IKK Signals in Lymphocyte Physiology and Pathology
淋巴细胞生理学和病理学中的 IKK 信号
- 批准号:
6985318 - 财政年份:2003
- 资助金额:
$ 44.8万 - 项目类别:
相似海外基金
Development of back bone vectors for chimeric antigen receptors against key molecules, CD47 and CD24, activating macrophages
开发针对关键分子 CD47 和 CD24 的嵌合抗原受体的骨干载体,激活巨噬细胞
- 批准号:
23K06728 - 财政年份:2023
- 资助金额:
$ 44.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Engineering next-generation chimeric antigen receptors for cancer immunotherapy using phospho-proteomics
职业:利用磷酸蛋白质组学设计用于癌症免疫治疗的下一代嵌合抗原受体
- 批准号:
2145853 - 财政年份:2022
- 资助金额:
$ 44.8万 - 项目类别:
Continuing Grant
Construction of a drug discovery platform utilizing antigen receptors that regulate the quality of cancer immunity
利用调节癌症免疫质量的抗原受体构建药物发现平台
- 批准号:
22K06603 - 财政年份:2022
- 资助金额:
$ 44.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Engineering synthetic adhesion receptors to enhance the sensitivity of therapeutic chimeric antigen receptors
工程合成粘附受体以增强治疗性嵌合抗原受体的敏感性
- 批准号:
MR/W031353/1 - 财政年份:2022
- 资助金额:
$ 44.8万 - 项目类别:
Research Grant
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10701754 - 财政年份:2022
- 资助金额:
$ 44.8万 - 项目类别:
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
- 批准号:
10557760 - 财政年份:2022
- 资助金额:
$ 44.8万 - 项目类别:
Chimeric antigen receptors on regulatory T cells as a treatment strategy in auto-immune diseases.
调节性 T 细胞上的嵌合抗原受体作为自身免疫性疾病的治疗策略。
- 批准号:
437200 - 财政年份:2020
- 资助金额:
$ 44.8万 - 项目类别:
Studentship Programs
Molecualr imaging for development of chimeric antigen receptors (CARs) resistant to T cell exhaustion
用于开发抗 T 细胞耗竭的嵌合抗原受体 (CAR) 的分子成像
- 批准号:
20H03536 - 财政年份:2020
- 资助金额:
$ 44.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
10542442 - 财政年份:2020
- 资助金额:
$ 44.8万 - 项目类别:
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
- 批准号:
9922602 - 财政年份:2020
- 资助金额:
$ 44.8万 - 项目类别:














{{item.name}}会员




